Senpras 100, 300 & 400 100 mg, 300 mg, 400 mg Capsule
PDF Leaflet Revision Date: 14 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Control of simple and complex partial seizures in adults and children over 12 years.
Dosage (summary)
Initial: 300 mg once daily, increase to 900-1800 mg/day in divided doses.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not established; avoid in pregnancy and breastfeeding.
Key Drug Interactions
- CNS depressants
- Opioids
- Antacids
Contraindications
- Hypersensitivity to gabapentin
- Severe renal impairment
- Children under 12 years
Common side effects
- Dizziness
- Somnolence
- Fatigue
- Nausea
Counselling Points
- Avoid driving until effects are known
- Monitor for signs of suicidal thoughts
- Take with sufficient fluid
Serious warnings
- Risk of suicidal ideation
- Anaphylaxis
- DRESS syndrome
Important Disclaimer
The Senpras 100, 300 & 400 100 mg, 300 mg, 400 mg Capsule professional information leaflet below is the property of Strides Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
